Submit or Track your Manuscript LOG-IN

Cytotoxic Effect of MTH1 Gene Silencing in Gemcitabine Resistant Breast Cancer Cells

Cytotoxic Effect of MTH1 Gene Silencing in Gemcitabine Resistant Breast Cancer Cells

Mahak Fatima1, Memoona Syed1, Rabia Zeeshan2, Farah Rauf Shakoori3, Naveed Shahzad4, Moazzam Ali1 and Zeeshan Mutahir1*

1Institute of Biochemistry and Biotechnology, University of the Punjab, 54590 Lahore, Pakistan
2Interdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus, 54000 Lahore, Pakistan
3Department of Zoology, University of the Punjab, 54590 Lahore, Pakistan
4School of Biological Sciences, University of the Punjab, 54590 Lahore, Pakistan

*      Corresponding author: zeeshan.ibb@pu.edu.pk

ABSTRACT

Nudix hydrolase 1 (NUDT1) or human MutT homolog 1 (MTH1) catalyzes the conversion of oxidized purine nucleotides to their monophosphate forms, thus preventing their incorporation into DNA and subsequently to oxidative damage. The present study explores the relationship between MTH1 gene silencing and its outcome on the growth of gemcitabine resistant breast cancer cells named MCF7-R. For this purpose, we transfected MCF7-R cells with MTH1 specific validated siRNA. Successful transfection of siRNA and consequent cytotoxicity in MCF7-R cells was confirmed by qRT-PCR, western blotting and cell viability assay. As a result of siRNA transfection, MTH1 protein was knockdown to approximately 77% in the transfected sample and resulted in a 1.75-fold increase in sensitivity of MCF7-R cells to gemcitabine. Moreover, higher expression of p21 protein was also observed in transfected MCF7-R cells that may indicate induced cell death. This study highlights the effect of MTH1 gene silencing in drug-resistant cancer cells as a mean to improve combined therapies for targeting drug-resistant cancers.
 

To share on other social networks, click on P-share. What are these?

Pakistan Journal of Zoology

October

Vol. 52, Iss. 5, Pages 1631-2026

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe